How is Deutsche Bank doing now?

Some people claim Deutsche Bank has collapsed—but that’s not true. It’s simply no longer as prominent as it once was. Below is an analysis of Deutsche Bank’s current situation from multiple perspectives: I. Financial Condition - Profitability: Since 2020, Deutsche Bank has implemented a series of strategic adjustments and has posted profits for several consecutive years. In 2022, its net profit exceeded €5 billion—the highest since 2007. In 2024, despite impacts from litigation expenses and restructuring costs, its revenue still rose 4% year-on-year to €30.1 billion. - Asset Size: As of the end of 2022, Deutsche Bank’s total assets exceeded €1.3 trillion, making it a bank with enormous asset scale. II. Market Confidence and Stock Price Volatility - Stock Price Volatility: In March 2023, amid the successive closures of U.S. banks and resulting turmoil in European stock markets, Deutsche Bank’s share price plunged sharply. However, such short-term stock fluctuations do not signify the bank’s overall collapse. - Restoration of Market Confidence: Although market confidence in Deutsche Bank had temporarily wavered, it is gradually recovering thanks to the bank’s sustained profitability and proactive measures by management.

What are the reasons Deutsche Bank maintains its 'Hold' rating?

Deutsche Bank holds derivatives positions worth tens of trillions of euros—an amount so massive it could be likened to a nuclear bomb, or even to a financial doomsday scenario. Failing to maintain Deutsche Bank’s stability and healthy trajectory would amount to financial suicide. Perhaps some short-sellers might seek to profit from a Deutsche Bank crisis—but rational investors would avoid exposure to such extreme risk. Fortunately, rationality has prevailed in the market.

Deutsche Bank Adjusts DuPont de Nemours Price Target to $60 From $58, Maintains Buy Rating

May 7, 2026

Deutsche Bank raised its price target for DuPont de Nemours to $60 and maintained a Buy rating following strong Q1 2026 earnings and raised 2026 guidance.

www.marketscreener.com

2026-04-21

UBS Raises Corteva Price Target to $88, Maintains Neutral Rating

2026-04-22

DuPont de Nemours Inc. Stock Underperforms vs Competitors on Wednesday

2026-04-24

DuPont’s Electronics Spinoff Qnity Prices $4.1B Debt Deal Ahead of November Split

2026-04-24

RBC Adjusts Price Target on DuPont de Nemours to $56 From $60, Maintains Outperform Rating

2026-04-28

Morgan Stanley Adjusts DuPont de Nemours Price Target to $52 From $44, Maintains Equal Weight Rating